· Updated · Venture Capital Tracker · investment-strategies  · 3 min read

Cincinnati Startups and VC Firms in 2026: 84.51°, CincyTech, Medpace

Cincinnati venture map in 2026 — Kroger’s 84.51° data science, Assurex Health’s GeneSight exit, Medpace (CRO), plus CincyTech and QCA Ventures.

Cincinnati Startups and VC Firms in 2026: 84.51°, CincyTech, Medpace

Cincinnati is a CPG/retail data and health services market — 84.51° (Kroger’s insights engine), Medpace as a public CRO, Assurex Health’s pharmacogenomics exit — with CincyTech and QCA Ventures as the seed stack.

This page maps what we profile.

City hub: /vc/cincinnati · All cities: /cities · Fund directory: /directory

What Cincinnati is (and is not)

Cincinnati is…Cincinnati is not…
Retail media / CPG data density via 84.51° + Kroger adjacencyA coastal consumer marketplace HQ market
Active seed via CincyTech and QCA (ex–Queen City Angels)Columbus insurtech (/vc/columbus-oh)
Health services (Medpace CRO) and GeneSight historyA full University City biotech census

Startups we cover in Cincinnati

CompanyWhat they doStage / statusNotable capitalProfile
84.51°Kroger’s retail data science, insights, and media subsidiary named for Cincinnati HQ longitude.OtherWholly owned by The Kroger Co./startup/eighty-four-fifty-one
Assurex HealthPharmacogenomic testing (GeneSight) to guide mental health medication decisions — acquired by Myriad Genetics.AcquiredCincyTech/startup/assurex-health
MedpaceFull-service clinical research organization (CRO) for biotech and pharma drug development.PublicNASDAQ:MEDP/startup/medpace

Why these names matter

84.51° — Cincinnati CPG/retail tech proof: wholly owned Kroger subsidiary at 100 W. Fifth Street turning first-party shopper data into insights and retail media.

Assurex Health — Cincinnati-metro (Mason, OH) precision-medicine exit: Myriad deal $225M upfront (+$185M milestones) in 2016; early CincyTech support; HQ kept in Mason.

Medpace — Cincinnati public life-sciences services scale-up (NASDAQ:MEDP) — local CRO density for founders commercializing trials.

Local investors (Cincinnati HQ or program)

FirmRoleStagesProfile
CincyTechCincinnati seed firm — among Midwest’s most active seed investorsPre-Seed, Seed/fund/cincytech
QCA VenturesCincinnati early-stage network (formerly Queen City Angels)Seed, Series A/fund/qca-ventures

How to read this: CincyTech and QCA are first-money paths. 84.51° is a Kroger subsidiary — use it as a buyer/talent proof point, not as a classic venture-backed startup peer.

National capital Cincinnati founders still need

Local funds rarely replace a coastal or specialist Series A. Pitch these directory firms by thesis, not geography:

FirmWhy founders careProfile
Andreessen HorowitzMulti-stage when consumer/data metrics clear/fund/andreessen-horowitz
Bessemer Venture PartnersVertical SaaS / data companies/fund/bessemer-venture-partners
Define VenturesDigital health specialist/fund/define-ventures
F-Prime CapitalHealthtech / life sciences/fund/f-prime-capital
General CatalystMulti-stage health + enterprise/fund/general-catalyst

Cincy seed vs national health/retail capital — what differs

CincyTech / QCANational Series A+
Best forPre-seed/seed, Ohio Third Frontier adjacencyScaled retail-tech or health rounds
Check shapeSeed network checksSpecialist priced rounds
UnderwriteLocal CPG/health buyersNational category leadership
MistakeTreating 84.51° as an independent seed-stage startupSkipping CincyTech when you have true Cincinnati HQ

Worked example (illustrative)

Setup: A Cincinnati retail-media or pharmacogenomic software startup raises CincyTech seed and lands a Kroger-adjacent or health-system pilot.

Move: They raise an $10–15M Series A from a national digital-health or data firm.

Punch: Cincinnati buyer access was the diligence artifact; the Series A lead was still national.

When Cincinnati is the wrong capital market

  • You need Drive Capital’s Columbus multi-stage story — use /vc/columbus-oh.
  • You treat Assurex as independent — it was acquired by Myriad.
  • You invent Queen City multi-stage HQ funds beyond CincyTech/QCA.
  • You pitch coastal consumer funds with zero CPG/retail proof.

How to use this page

  1. Read 84.51°, Assurex Health, Medpace.
  2. Local: CincyTech, QCA Ventures.
  3. Live hub: /vc/cincinnati.
  4. Midwest peers: Columbus and Cleveland hubs.

Sources

  1. Startup profiles: eighty-four-fifty-one, assurex-health, medpace
  2. Fund profiles: cincytech, qca-ventures

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

Frequently Asked Questions

Common questions about this topic

Back to Blog

Recommended next

Browse all research »

Nua’s $50M Series C Mixes Primary and Secondary — No Split, No Valuation

Peak XV and Filter Capital led a $50 million (~₹472 crore) Series C for Mumbai women’s-wellness brand Nua on September 7, 2026. The company said the print mixes primary capital and secondaries. Inc42 had reported $20–25 million talks. Valuation was not disclosed. ₹500 crore annualised run rate is a company claim.